Skip to main content

Day: April 28, 2021

XDD Acquires Paralaw UK Limited to Expand Managed Reviewer and eDiscovery Services Talent Pool in UK

MISSION, Kan., April 28, 2021 (GLOBE NEWSWIRE) — Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, announces the acquisition of Paralaw, a UK-based legal outsourcing company providing managed review staffing, eDiscovery and contracts management services to law firms and corporations. The acquisition expands XDD’s UK footprint via its Anexsys brand, providing an internal pool of legal outsource talent to fulfill core managed review, eDiscovery and contracts management services in the UK region. Based in London, UK for over 20 years, Paralaw provides clients with flexible outsourced legal support to both in-house legal teams and law firms, with clients ranging from start-ups to established firms, technology providers and blue chip...

Continue reading

Captor Capital Announces Non-Brokered Private Placement

TORONTO, April 28, 2021 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUTTGART: NMVA), (“Captor” or the “Company”), one of the largest cannabis retail operators in Northern California, is pleased to announce that it has received irrevocable subscriptions in respect of a non-brokered private placement (the “Non-Brokered Offering”) of 12,485,072 units (“Units”) that will result in gross proceeds of C$11,860,818.40. Each Unit has a purchase price of C$0.95 and is comprised of one common share of the Company (a “Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will be exercisable to acquire one Common Share (a “Warrant Share”) at an exercise price of C$1.20 per Warrant Share for a period of 24 months from the closing. The...

Continue reading

Landstar to Participate in Oppenheimer’s 16th Annual Industrial Growth Conference

JACKSONVILLE, Fla., April 28, 2021 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ:LSTR) announced today its participation in Oppenheimer’s 16th Annual Industrial Growth Conference. Landstar’s “fireside chat” discussion begins at 10:30 a.m. ET on Tuesday, May 4. It will be broadcast live via the Internet at www.investor.landstar.com; click on “Webcasts.” The Oppenheimer presentation will be available on Landstar’s website through May 11. For more information about the presentations or webcasts, please contact Landstar’s Investor Relations department at 904-390-1334 or email kviergutz@landstar.com. About Landstar: Landstar System, Inc. is a worldwide, asset-light provider of integrated transportation management solutions delivering safe, specialized transportation services to a broad range of customers utilizing a network...

Continue reading

Home Infusion Therapy Market Size 2021 | Is Likely to Reach USD 86.89 Billion with 2.2% CAGR by 2027

Top Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players Pune, India, April 28, 2021 (GLOBE NEWSWIRE) — The global home infusion therapy market size is likely to Reach USD 86.89 Billion by the end of 2027 owing to the increasing adoption of home medical services worldwide. In a home infusion therapy setting, a patient receives all medical assistance at home including drugs and biologics via a subcutaneous or an intravenous administrative route. According to a recent report by Fortune Business Insights titled, “Home Infusion Therapy Market Size, Share & Industry Analysis, By Product (Devices, Drugs, and Services)...

Continue reading

Q1 2021 Trading Statement

Company Announcement No 21/2020 – 28 April 2021 Q1 2021 Trading Statement Q1 2021 Strong start in Off-Trade Statement by Royal Unibrew’s CEO Lars Jensen: “We are off to a solid start to the year with strong execution in the Off-Trade business, especially in Denmark and Italy. We are once again delivering record high volumes, net revenue and EBIT driven by an Off-Trade business where all key markets have outperformed last year. The organization has exploited the opportunities that the markets have offered, and we have continued to win market shares across most markets and categories. Our On-Trade and Border businesses have been negatively affected by the restrictions imposed as a result of the pandemic throughout the quarter, and in March our On-Trade business was down by more than 60% compared to 2019. Under these difficult circumstances...

Continue reading

Decisions at Annual General Meeting of Klövern AB (publ)

At the Annual General Meeting of Klövern AB (publ) on 28 April 2021 the following decisions were made, among others. Dividend A dividend of SEK 0.26 per ordinary share of Class A and Class B and SEK 20.00 per preference share for the 2020 financial year was decided. The dividend amount per ordinary share of Class A and Class B shall be paid in two instalments of SEK 0.13. The dividend amount per preference share shall be paid in four instalments of SEK 5.00. The record dates for dividend for ordinary shares shall be 30 September 2021 with expected payment date being 5 October 2021, and 31 March 2022 with expected payment date being 5 April 2022. The record dates for dividend for preference shares shall be 30 June 2021 with expected payment date being 5 July 2021, 30 September 2021 with expected payment date being 5 October 2021, 30 December...

Continue reading

Sterile Medical Packaging Market to Reach USD 47.89 Billion by 2027; Demand for Robust Packaging Solutions to Augment Growth, Says Fortune Business Insights™

Key companies covered are Oliver Healthcare Packaging, GS Medical Packaging, Orchid, Techinipaq Inc., Amcor Plc., Placon, DuPont, Steripack Ltd., Wipak Group, Nelipak Healthcare, Tekni-Plex, Sonoco, BillerudKorsnäs AB, ProAmpac, West Pharmaceutical Services, Inc., Riverside Medical Packaging Company Ltd, and other players profiled in sterile medical packaging market research report Pune, India, April 28, 2021 (GLOBE NEWSWIRE) — The global sterile medical packaging market size stood 31.38 Billion in 2019 and is expected to reach USD 47.89 billion by 2027, exhibiting a CAGR of 5.5% during the forecast period. The growing cognizance about the advantageous properties of sterile medical packaging such as tear resistance, durability, breathability, and the superior microbial barrier will promote the growth of the market during the forecast...

Continue reading

The Chefs’ Warehouse Reports First Quarter 2021 Financial Results

RIDGEFIELD, Conn., April 28, 2021 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States and Canada, today reported financial results for its first quarter ended March 26, 2021. Financial highlights for the first quarter of 2021:Net sales decreased 25.4% to $280.2 million for the first quarter of 2021 from $375.4 million for the first quarter of 2020. GAAP net loss was $17.9 million, or $(0.49) per diluted share, for the first quarter of 2021 compared to net loss of $14.1 million, or $(0.48) per diluted share, in the first quarter of 2020. Adjusted EPS1 was $(0.50) for the first quarter of 2021 compared to $(0.60) for the first quarter of 2020. Adjusted EBITDA1 was $(9.5) million for the first quarter of 2021 compared to $(13.8)...

Continue reading

FibroGen to Present at Upcoming Investor Conference

SAN FRANCISCO, April 28, 2021 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2021 Virtual Health Care Conference on May 13, 2021 at 5:00 PM Eastern Time. A live audio webcast will be available on the “Events & Presentations” section of the FibroGen Investor webpage at www.fibrogen.com. A replay will be available for approximately 30 days. About FibroGen FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines for the treatment of unmet needs. The Company is currently...

Continue reading

Stone Gold Inc. Announces the Appointment of Birks Bovaird to Its Board of Directors

TORONTO, April 28, 2021 (GLOBE NEWSWIRE) — Stone Gold Inc. (TSX-V: STG) (“Stone Gold” or the “Company“) announces the appointment of Birks Bovaird to its Board of Directors. Mr. Bovaird is a Consultant, providing advisory services to natural resource companies. For the majority of his career, Mr. Bovaird’s focus has been the provision and implementation of corporate financial consulting and strategic planning services. After spending over two decades with various financial institutions, culminating in the role of Managing Director of the Canadian operations of an international bank, he took on the role of Vice President of Corporate Finance for one of Canada’s major accounting firms.  Mr. Bovaird has previously been involved with numerous public resource and non-resource companies, both as a member...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.